1. RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center
- Author
-
Caterina De Luca, Francesco Pepe, Pasquale Pisapia, Antonino Iaccarino, Luisella Righi, Angela Listì, Gianluca Russo, Severo Campione, Fabio Pagni, Mariantonia Nacchio, Floriana Conticelli, Maria Russo, Teresa Fabozzi, Elena Vigliar, Claudio Bellevicine, Danilo Rocco, Stefano Laudati, Giuseppe Iannaci, Bruno Daniele, Cesare Gridelli, Diego Luigi Cortinovis, Silvia Novello, Miguel Angel Molina-Vila, Rafael Rosell, Giancarlo Troncone, Umberto Malapelle, Luca, C, Pepe, F, Pisapia, P, Iaccarino, A, Righi, L, Listi, A, Russo, G, Campione, S, Pagni, F, Nacchio, M, Conticelli, F, Russo, M, Fabozzi, T, Vigliar, E, Bellevicine, C, Rocco, D, Laudati, S, Iannaci, G, Daniele, B, Gridelli, C, Cortinovis, D, Novello, S, Molina-Vila, M, Rosell, R, Troncone, G, Malapelle, U, DE LUCA, Caterina, Pepe, Francesco, Pisapia, Pasquale, Iaccarino, Antonino, Righi, Luisella, Listì, Angela, Russo, Gianluca, Campione, Severo, Pagni, Fabio, Nacchio, Mariantonia, Conticelli, Floriana, Russo, Maria, Fabozzi, Teresa, Vigliar, Elena, Bellevicine, Claudio, Rocco, Danilo, Laudati, Stefano, Iannaci, Giuseppe, Daniele, Bruno, Gridelli, Cesare, Luigi Cortinovis, Diego, Novello, Silvia, Angel Molina-Vila, Miguel, Rosell, Rafael, Troncone, Giancarlo, and Malapelle, Umberto
- Subjects
Pharmacology ,Lung Neoplasms ,ALK ,IHC ,MET ,NGS ,NSCLC ,NTRK ,RET ,ROS1 ,molecular oncology ,predictive molecular pathology ,High-Throughput Nucleotide Sequencing ,General Medicine ,Protein-Tyrosine Kinases ,Carcinoma, Non-Small-Cell Lung ,Proto-Oncogene Proteins ,Humans ,RNA ,Molecular Medicine ,Anaplastic Lymphoma Kinase ,Referral and Consultation - Abstract
Aim: ALK, ROS1, NTRK and RET gene fusions and MET exon 14 skipping alterations represent novel predictive biomarkers for advanced non-small-cell lung cancer (NSCLC). Therefore, testing patients for these genetic variants is crucial for choosing the best selective treatment. Over the last couple of decades, next-generation sequencing (NGS) platforms have emerged as an extremely useful tool for detecting these variants. Materials & methods: In the present study, we report our NGS molecular records produced during a year of diagnostic activity. Results: Overall, our in-house developed NGS workflow successfully analyzed n = 116/131 (88.5%) NSCLC samples. Of these, eight (6.8%) and five (4.3%) out of 116 patients harbored ALK and RET gene rearrangements, respectively: one case harbored ROS1 gene fusion (0.7%). Conclusion: Our results highlight that an RNA-based NGS analysis can reliably detect gene fusion alterations, thereby playing a pivotal role in the management of NSCLC patients.
- Published
- 2022
- Full Text
- View/download PDF